Long-term hypothermic lung preservation: Does adenosine A1 receptor antagonism have a role in ischemic preconditioning protection?

Interactive Cardiovascular and Thoracic Surgery

Volumn 3, Issue 1, 2004, Pages 182-187

  Featherstone, Roland L ^a   Chambers, David J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Adenosine receptor; Antagonists; Lung; Preconditioning; Preservation; Rat

Indexed keywords

8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; CARDIOPLEGIC AGENT; ENPROFYLLINE; PHOSPHODIESTERASE INHIBITOR; THEOPHYLLINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; DRUG EFFECT; ENZYME INHIBITION; HEART INFARCTION PREVENTION; ISOLATED LUNG; LUNG; LUNG FUNCTION; LUNG PERFUSION; LUNG VENTILATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

EID: 1842736354     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9293(03)00274-3     Document Type: Article

References (14)

1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
2. Cohen M.V., Baines C.P., Downey J.M. Ischemic preconditioning: from adenosine receptor of KATP channel. Annu Rev Physiol. 62:2000;79-109.
3. Cave A.C., Collis C.S., Downey J.M., Hearse D.J. Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovasc Res. 27:1993;663-668.
4. Neely C.F., Keith I.M. A1 adenosine receptor antagonists block ischemia-reperfusion injury of the lung. Am J Physiol. 268:1995;L1036-L1046.
5. Featherstone R.L., Chambers D.J., Kelly F.J. Ischemic preconditioning enhances recovery of isolated rat lungs after hypothermic preservation. Ann Thorac Surg. 69:2000;237-242.
6. Featherstone R.L., Chambers D.J., Kelly F.J. Comparison of phosphodiesterase inhibitors of differing isoenzyme selectivity added to St. Thomas' hospital cardioplegic solution used for hypothermic preservation of rat lungs. Am J Respir Crit Care Med. 162:2000;850-856.
7. Schwabe U., Ukena D., Lohse M.J. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol. 330:1985;212-221.
8. Persson C.G., Karlsson J.A., Erjefalt I. Differentiation between bronchodilation and universal adenosine antagonism among xanthine derivatives. Life Sci. 30:1982;2181-2189.
9. Klotz K.N., Vogt H., Tawfik-Schlieper H. Comparison of A1 adenosine receptors in brain from different species by radioligand binding and photoaffinity labelling. Naunyn Schmiedebergs Arch Pharmacol. 343:1991;196-201.
10. Uhlig S., Wollin L. An improved setup for the isolated perfused rat lung. J Pharmacol Toxicol Methods. 31:1994;85-94.
11. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal Biochem. 150:1985;76-85.
12. Bhabra M.S., Hopkinson D.N., Shaw T.E., Hooper T.L. Critical importance of the first 10 minutes of lung graft reperfusion after hypothermic storage. Ann Thorac Surg. 61:1996;1631-1635.
13. Schudt C., Winder S., Muller B., Ukena D. Zardaverine as a selective inhibitor of phosphodiesterase isozymes. Biochem Pharmacol. 42:1991;153-162.
14. Ukena D., Schudt C., Sybrecht G.W. Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes. Biochem Pharmacol. 45:1993;847-851.